APA (7 ম সংস্করণ) উদ্ধৃতি

(17078830), Q. X., (17078833), K. H., (17078836), X. M., (17078839), Y. W., (17078842), L. Z., (17078845), L. B., . . . (17078857), Q. C. (2025). Supplementary Table S3 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma.

শিকাগো স্টাইল (17 তম সংস্করণ) উদ্ধৃতি

(17078830), Qingsheng Xu, et al. Supplementary Table S3 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma. 2025.

M.L.A (9 ম সংস্করণ) উদ্ধৃতি

(17078830), Qingsheng Xu, et al. Supplementary Table S3 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma. 2025.